Evidence map›Paper›PMID 38044344›Full record

ArticleNature communications2023

Regulation of the cell division hydrolase RipC by the FtsEX system in Mycobacterium tuberculosis.

Jianwei Li, Xin Xu, Jian Shi, Juan A Hermoso, Lok-To Sham, Min Luo

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Unique growth and morphology properties of Clade 5bioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianwei Li *Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Singapore.ORCID 0000-0001-9181-4760
Xin Xu *Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Singapore.
Jian ShiCenter for Bioimaging Sciences, Department of Biological Sciences, National University of Singapore, Singapore, Singapore.
Juan A HermosoDepartment of Crystallography and Structural Biology, Instituto de Química-Física "Blas Cabrera", Consejo Superior de Investigaciones Científicas, Madrid, Spain. xjuan@iqfr.csic.es.ORCID 0000-0002-1862-8950
Lok-To ShamInfectious Diseases Translational Research Programme and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. lsham@nus.edu.sg.ORCID 0000-0001-9047-0310
Min LuoDepartment of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Singapore. dbslmin@nus.edu.sg.ORCID 0000-0002-3493-2282

Funding

Ministry of Education - Singapore (MOE) 22-3448-A0001Ministry of Education - Singapore (MOE) 22-3449-A0001Ministry of Education - Singapore (MOE) MOE-T2EP30222-0015
6 · The paper itself

Abstract

The FtsEX complex regulates, directly or via a protein mediator depending on bacterial genera, peptidoglycan degradation for cell division. In mycobacteria and Gram-positive bacteria, the FtsEX system directly activates peptidoglycan-hydrolases by a mechanism that remains unclear. Here we report our investigation of Mycobacterium tuberculosis FtsEX as a non-canonical regulator with high basal ATPase activity. The cryo-EM structures of the FtsEX system alone and in complex with RipC, as well as the ATP-activated state, unveil detailed information on the signal transduction mechanism, leading to the activation of RipC. Our findings indicate that RipC is recognized through a "Match and Fit" mechanism, resulting in an asymmetric rearrangement of the extracellular domains of FtsX and a unique inclined binding mode of RipC. This study provides insights into the molecular mechanisms of FtsEX and RipC regulation in the context of a critical human pathogen, guiding the design of drugs targeting peptidoglycan remodeling.

Indexed as

Cell Cycle ProteinsMycobacterium tuberculosisBacterial ProteinsCell DivisionHumansHydrolasesPeptidoglycanBacterial ProteinsCell Cycle ProteinsHydrolasesPeptidoglycan

Identifiers

PMID38044344
PMCPMC10694151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.